Cigna earnings beat by $0.04, revenue topped estimates
Julie Jarecke Gebauer, President of Health, Wealth & Career at Willis Towers Watson PLC (NASDAQ:WTW), recently sold 3,384 ordinary shares of the company. The transaction, which took place on February 28, 2025, was executed at an average price of approximately $335.77 per share, totaling $1,136,243. Following this sale, Gebauer holds 74,417.321 shares directly. Additionally, separate holdings in management trusts named after Dane Adam Gebauer and Jeffrey Austin Gebauer each contain 534 shares. The transaction was completed through multiple trades with prices ranging from $335.16 to $336.00. According to InvestingPro analysis, WTW appears fairly valued at current levels, with analysts setting price targets ranging from $302 to $408 per share. For deeper insights into WTW’s valuation and growth prospects, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Willis Towers Watson reported several significant developments. Jefferies revised its price target for the company to $373, down from $382, while maintaining a "Buy" rating. The adjustment was due to investments in reinsurance and increased expenses, but Jefferies remains optimistic about the firm’s future margins. Similarly, Goldman Sachs lowered its price target to $378, citing non-core factors like foreign exchange rates and startup costs, yet upheld a "Buy" rating based on strong free cash flow growth projections. BMO Capital Markets also adjusted its price target to $320, maintaining a Market Perform rating, noting a decrease in earnings estimates but highlighting an upward trend in free cash flow margins. In another development, Willis Towers Watson appointed Helen Campbell as the new Head of Property Wordings for North America, enhancing their property policy clarity. Additionally, the company launched a new Guidewire (NYSE:GWRE) accelerator to improve insurance analytics, aiming to streamline pricing and underwriting processes for insurers. These recent developments reflect Willis Towers Watson’s strategic initiatives and market positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.